Imad Hanna

Imad Hanna is an accomplished professional in the field of pharmacology, currently serving as a Director at Novartis Institutes for BioMedical Research (NIBR) since 2003, focusing on drug metabolism and pharmacokinetics in discovery research for oncology and infectious diseases. Additionally, Imad holds the position of Adjunct Associate Professor in the Department of Pharmacology and Toxicology at Rutgers University since March 2015. Prior to these roles, Imad was an Associate Principal Scientist at Schering Plough from June 2000 to July 2003, specializing in in vitro drug metabolism studies. Educational qualifications include a PhD in Pharmacology from Wayne State University and a BS in Biochemistry from Oakland University.